ntic20220228_10q.htm
0000875582 Northern Technologies International Corporation false --08-31 Q2 2022 382,000 382,000 0 0 10,000 10,000 0 0 0 0 0.02 0.02 15,000,000 15,000,000 9,221,517 9,221,517 9,184,811 9,184,811 15.3 15 50 423,000 423,000 423,000 423,000 1.10 0 0 72,418 0 0 0 311,061 136,221 10 1 3 Includes Harita-NTI since Harita-NTI was not a consolidated subsidiary of the Company as of Augut 31, 2021 or November 30, 2020. See Note 3. The percent of segment sales is calculated by dividing the direct cost of goods sold for each individual segment category by the net sales for each segment category. 00008755822021-09-012022-02-28 xbrli:shares 00008755822022-04-05 iso4217:USD 00008755822022-02-28 00008755822021-08-31 0000875582ntic:PatentsAndTrademarksMember2022-02-28 0000875582ntic:PatentsAndTrademarksMember2021-08-31 0000875582ntic:IntangibleAssetsExcludingPatentsAndTrademarksMember2022-02-28 0000875582ntic:IntangibleAssetsExcludingPatentsAndTrademarksMember2021-08-31 iso4217:USDxbrli:shares 00008755822021-12-012022-02-28 00008755822020-12-012021-02-28 00008755822020-09-012021-02-28 0000875582us-gaap:CommonStockMember2021-11-30 0000875582us-gaap:AdditionalPaidInCapitalMember2021-11-30 0000875582us-gaap:RetainedEarningsMember2021-11-30 0000875582us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-11-30 0000875582us-gaap:NoncontrollingInterestMember2021-11-30 00008755822021-11-30 0000875582us-gaap:CommonStockMember2021-12-012022-02-28 0000875582us-gaap:AdditionalPaidInCapitalMember2021-12-012022-02-28 0000875582us-gaap:RetainedEarningsMember2021-12-012022-02-28 0000875582us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-012022-02-28 0000875582us-gaap:NoncontrollingInterestMember2021-12-012022-02-28 0000875582us-gaap:CommonStockMember2022-02-28 0000875582us-gaap:AdditionalPaidInCapitalMember2022-02-28 0000875582us-gaap:RetainedEarningsMember2022-02-28 0000875582us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-02-28 0000875582us-gaap:NoncontrollingInterestMember2022-02-28 0000875582us-gaap:CommonStockMember2020-11-30 0000875582us-gaap:AdditionalPaidInCapitalMember2020-11-30 0000875582us-gaap:RetainedEarningsMember2020-11-30 0000875582us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-11-30 0000875582us-gaap:NoncontrollingInterestMember2020-11-30 00008755822020-11-30 0000875582us-gaap:CommonStockMember2020-12-012021-02-28 0000875582us-gaap:AdditionalPaidInCapitalMember2020-12-012021-02-28 0000875582us-gaap:RetainedEarningsMember2020-12-012021-02-28 0000875582us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-012021-02-28 0000875582us-gaap:NoncontrollingInterestMember2020-12-012021-02-28 0000875582us-gaap:CommonStockMember2021-02-28 0000875582us-gaap:AdditionalPaidInCapitalMember2021-02-28 0000875582us-gaap:RetainedEarningsMember2021-02-28 0000875582us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-02-28 0000875582us-gaap:NoncontrollingInterestMember2021-02-28 00008755822021-02-28 0000875582us-gaap:CommonStockMember2021-08-31 0000875582us-gaap:AdditionalPaidInCapitalMember2021-08-31 0000875582us-gaap:RetainedEarningsMember2021-08-31 0000875582us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-08-31 0000875582us-gaap:NoncontrollingInterestMember2021-08-31 0000875582us-gaap:CommonStockMember2021-09-012022-02-28 0000875582us-gaap:AdditionalPaidInCapitalMember2021-09-012022-02-28 0000875582us-gaap:RetainedEarningsMember2021-09-012022-02-28 0000875582us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-012022-02-28 0000875582us-gaap:NoncontrollingInterestMember2021-09-012022-02-28 0000875582us-gaap:CommonStockMember2020-08-31 0000875582us-gaap:AdditionalPaidInCapitalMember2020-08-31 0000875582us-gaap:RetainedEarningsMember2020-08-31 0000875582us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-08-31 0000875582us-gaap:NoncontrollingInterestMember2020-08-31 00008755822020-08-31 0000875582us-gaap:CommonStockMember2020-09-012021-02-28 0000875582us-gaap:AdditionalPaidInCapitalMember2020-09-012021-02-28 0000875582us-gaap:RetainedEarningsMember2020-09-012021-02-28 0000875582us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-09-012021-02-28 0000875582us-gaap:NoncontrollingInterestMember2020-09-012021-02-28 xbrli:pure 0000875582ntic:HaritaNTILimitedMember2021-09-01 0000875582ntic:HaritaNTILimitedMember2021-09-012021-09-01 0000875582us-gaap:RevolvingCreditFacilityMemberntic:PNCBankMember2021-09-01 0000875582ntic:HaritaNTILimitedMemberus-gaap:CustomerRelationshipsMember2021-09-01 0000875582ntic:HaritaNTILimitedMemberus-gaap:CustomerRelationshipsMember2021-09-012021-09-01 utr:Y 0000875582ntic:HaritaNTILimitedMemberntic:CustomerRelationshipsAndAssembledWorkforceMember2021-09-012021-09-01 0000875582ntic:HaritaNTILimitedMember2021-09-012022-02-28 0000875582ntic:HaritaNTILimitedMember2021-12-012022-02-28 0000875582us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2022-02-28 0000875582ntic:EXCORMember2022-02-28 0000875582ntic:AllOtherMember2022-02-28 0000875582us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2021-12-012022-02-28 0000875582ntic:EXCORMember2021-12-012022-02-28 0000875582ntic:AllOtherMember2021-12-012022-02-28 0000875582us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2021-09-012022-02-28 0000875582ntic:EXCORMember2021-09-012022-02-28 0000875582ntic:JointVenturesInFranceMember2021-09-012022-02-28 0000875582us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2021-08-31 0000875582ntic:EXCORMember2021-08-31 0000875582ntic:JointVenturesInFranceMember2021-08-31 0000875582us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2020-12-012021-02-28 0000875582ntic:EXCORMember2020-12-012021-02-28 0000875582ntic:JointVenturesInFranceMember2020-12-012021-02-28 0000875582us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2020-09-012021-02-28 0000875582ntic:EXCORMember2020-09-012021-02-28 0000875582ntic:JointVenturesInFranceMember2020-09-012021-02-28 0000875582us-gaap:CustomerRelationshipsMember2022-02-28 0000875582ntic:CustomerRelationshipsAndAssembledWorkforceMember2021-12-012022-02-28 0000875582ntic:CustomerRelationshipsAndAssembledWorkforceMember2021-09-012022-02-28 0000875582ntic:CustomerRelationshipsAndAssembledWorkforceMember2022-02-28 0000875582us-gaap:RevolvingCreditFacilityMemberntic:PNCBankMember2022-02-28 0000875582us-gaap:RevolvingCreditFacilityMemberntic:PNCBankMember2021-08-30 0000875582us-gaap:RevolvingCreditFacilityMemberntic:PNCBankMember2021-08-31 0000875582us-gaap:RevolvingCreditFacilityMemberntic:PNCBankMemberus-gaap:LondonInterbankOfferedRateLIBORMember2021-09-012022-02-28 0000875582us-gaap:RevolvingCreditFacilityMemberntic:PNCBankMember2022-02-22 0000875582us-gaap:RevolvingCreditFacilityMemberntic:PNCBankMemberus-gaap:SubsequentEventMember2022-04-23 0000875582us-gaap:RevolvingCreditFacilityMemberntic:PNCBankMemberus-gaap:SubsequentEventMember2022-04-24 0000875582us-gaap:RevolvingCreditFacilityMemberntic:PNCBankMember2021-09-012022-02-28 0000875582ntic:JPMorganChaseBankMember2022-02-28 0000875582ntic:JPMorganChaseBankMember2021-08-31 00008755822021-10-202021-10-20 thunderdome:item 00008755822022-01-212022-01-21 0000875582ntic:The2019PlanMemberntic:EmployeesAndDirectorsMember2021-09-012022-02-28 0000875582ntic:The2019PlanMemberntic:EmployeesAndDirectorsMember2020-09-012021-02-28 00008755822021-09-012021-09-01 00008755822020-09-012020-09-01 0000875582ntic:ESPPMember2022-02-28 0000875582us-gaap:EmployeeStockOptionMember2021-12-012022-02-28 0000875582us-gaap:EmployeeStockOptionMember2021-09-012022-02-28 0000875582us-gaap:EmployeeStockOptionMember2020-12-012021-02-28 0000875582us-gaap:EmployeeStockOptionMember2020-09-012021-02-28 0000875582ntic:The2019PlanMember2021-01-152021-01-15 0000875582ntic:The2019PlanMember2022-02-28 0000875582ntic:The2019PlanMember2021-09-012022-02-28 0000875582ntic:The2019PlanMembersrt:MinimumMemberntic:OneYearAfterDateOfGrantMember2021-09-012022-02-28 0000875582ntic:The2019PlanMembersrt:MaximumMemberntic:OneYearAfterDateOfGrantMember2021-09-012022-02-28 0000875582ntic:The2007PlanMember2022-02-28 0000875582ntic:ZERUSTMember2021-12-012022-02-28 0000875582ntic:ZERUSTMember2020-12-012021-02-28 0000875582ntic:ZERUSTMember2021-09-012022-02-28 0000875582ntic:ZERUSTMember2020-09-012021-02-28 0000875582ntic:NaturTecMember2021-12-012022-02-28 0000875582ntic:NaturTecMember2020-12-012021-02-28 0000875582ntic:NaturTecMember2021-09-012022-02-28 0000875582ntic:NaturTecMember2020-09-012021-02-28 0000875582ntic:DirectCostOfGoodsSoldMemberntic:ZERUSTMember2021-12-012022-02-28 0000875582ntic:DirectCostOfGoodsSoldMemberntic:ZERUSTMember2020-12-012021-02-28 0000875582ntic:DirectCostOfGoodsSoldMemberntic:ZERUSTMember2021-09-012022-02-28 0000875582ntic:DirectCostOfGoodsSoldMemberntic:ZERUSTMember2020-09-012021-02-28 0000875582ntic:DirectCostOfGoodsSoldMemberntic:NaturTecMember2021-12-012022-02-28 0000875582ntic:DirectCostOfGoodsSoldMemberntic:NaturTecMember2020-12-012021-02-28 0000875582ntic:DirectCostOfGoodsSoldMemberntic:NaturTecMember2021-09-012022-02-28 0000875582ntic:DirectCostOfGoodsSoldMemberntic:NaturTecMember2020-09-012021-02-28 0000875582ntic:IndirectCostOfGoodsSoldMember2021-12-012022-02-28 0000875582ntic:IndirectCostOfGoodsSoldMember2020-12-012021-02-28 0000875582ntic:IndirectCostOfGoodsSoldMember2021-09-012022-02-28 0000875582ntic:IndirectCostOfGoodsSoldMember2020-09-012021-02-28 0000875582ntic:InsideTheUSAToUnaffiliatedCustomersMember2021-12-012022-02-28 0000875582ntic:InsideTheUSAToUnaffiliatedCustomersMember2020-12-012021-02-28 0000875582ntic:InsideTheUSAToUnaffiliatedCustomersMember2021-09-012022-02-28 0000875582ntic:InsideTheUSAToUnaffiliatedCustomersMember2020-09-012021-02-28 0000875582ntic:JointVenturesInWhichTheCompanyIsAShareholderDirectlyAndIndirectlyOutsideTheUSAMember2021-12-012022-02-28 0000875582ntic:JointVenturesInWhichTheCompanyIsAShareholderDirectlyAndIndirectlyOutsideTheUSAMember2020-12-012021-02-28 0000875582ntic:JointVenturesInWhichTheCompanyIsAShareholderDirectlyAndIndirectlyOutsideTheUSAMember2021-09-012022-02-28 0000875582ntic:JointVenturesInWhichTheCompanyIsAShareholderDirectlyAndIndirectlyOutsideTheUSAMember2020-09-012021-02-28 0000875582ntic:UnaffiliatedCustomersOutsideTheUSAMember2021-12-012022-02-28 0000875582ntic:UnaffiliatedCustomersOutsideTheUSAMember2020-12-012021-02-28 0000875582ntic:UnaffiliatedCustomersOutsideTheUSAMember2021-09-012022-02-28 0000875582ntic:UnaffiliatedCustomersOutsideTheUSAMember2020-09-012021-02-28 0000875582country:DE2021-12-012022-02-28 0000875582country:DE2020-12-012021-02-28 0000875582country:PL2021-12-012022-02-28 0000875582country:PL2020-12-012021-02-28 0000875582country:JP2021-12-012022-02-28 0000875582country:JP2020-12-012021-02-28 0000875582country:FR2021-12-012022-02-28 0000875582country:FR2020-12-012021-02-28 0000875582country:SE2021-12-012022-02-28 0000875582country:SE2020-12-012021-02-28 0000875582country:GB2021-12-012022-02-28 0000875582country:GB2020-12-012021-02-28 0000875582country:TH2021-12-012022-02-28 0000875582country:TH2020-12-012021-02-28 0000875582country:FI2021-12-012022-02-28 0000875582country:FI2020-12-012021-02-28 0000875582country:CZ2021-12-012022-02-28 0000875582country:CZ2020-12-012021-02-28 0000875582country:KR2021-12-012022-02-28 0000875582country:KR2020-12-012021-02-28 0000875582ntic:OtherCountriesMember2021-12-012022-02-28 0000875582ntic:OtherCountriesMember2020-12-012021-02-28 0000875582country:DE2021-09-012022-02-28 0000875582country:DE2020-09-012021-02-28 0000875582country:PL2021-09-012022-02-28 0000875582country:PL2020-09-012021-02-28 0000875582country:JP2021-09-012022-02-28 0000875582country:JP2020-09-012021-02-28 0000875582country:FR2021-09-012022-02-28 0000875582country:FR2020-09-012021-02-28 0000875582country:SE2021-09-012022-02-28 0000875582country:SE2020-09-012021-02-28 0000875582country:TH2021-09-012022-02-28 0000875582country:TH2020-09-012021-02-28 0000875582country:KR2021-09-012022-02-28 0000875582country:KR2020-09-012021-02-28 0000875582country:FI2021-09-012022-02-28 0000875582country:FI2020-09-012021-02-28 0000875582country:CZ2021-09-012022-02-28 0000875582country:CZ2020-09-012021-02-28 0000875582country:GB2021-09-012022-02-28 0000875582country:GB2020-09-012021-02-28 0000875582ntic:OtherCountriesMember2021-09-012022-02-28 0000875582ntic:OtherCountriesMember2020-09-012021-02-28 0000875582country:CN2022-02-28 0000875582country:CN2021-08-31 0000875582ntic:OtherCountriesMember2022-02-28 0000875582ntic:OtherCountriesMember2021-08-31 0000875582country:US2022-02-28 0000875582country:US2021-08-31 0000875582country:CN2021-12-012022-02-28 0000875582country:CN2020-12-012021-02-28 0000875582country:BR2021-12-012022-02-28 0000875582country:BR2020-12-012021-02-28 0000875582country:IN2021-12-012022-02-28 0000875582country:IN2020-12-012021-02-28 0000875582country:US2021-12-012022-02-28 0000875582country:US2020-12-012021-02-28 0000875582country:CN2021-09-012022-02-28 0000875582country:CN2020-09-012021-02-28 0000875582country:BR2021-09-012022-02-28 0000875582country:BR2020-09-012021-02-28 0000875582country:IN2021-09-012022-02-28 0000875582country:IN2020-09-012021-02-28 0000875582country:US2021-09-012022-02-28 0000875582country:US2020-09-012021-02-28 0000875582ntic:Fiscal2018BonusPlanMembersrt:ExecutiveOfficerMember2021-09-012022-02-28 0000875582us-gaap:FairValueMeasurementsRecurringMember2022-02-28 0000875582us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-28 0000875582us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-28 0000875582us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-28 0000875582us-gaap:FairValueMeasurementsRecurringMember2021-08-31 0000875582us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-08-31 0000875582us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-08-31 0000875582us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-08-31 0000875582ntic:PatentsAndTrademarksMember2021-09-012022-02-28 0000875582ntic:FeesForServicesProvidedToJointVenturesMember2021-09-012022-02-28
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________________________

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended February 28, 2022

 or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________________ to __________________

 

Commission File Number: 001-11038

____________________

 

NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

(State or other jurisdiction of incorporation or organization)

41-0857886

(I.R.S. Employer Identification No.)

 

4201 Woodland Road

P.O. Box 69

Circle Pines, Minnesota 55014

(Address of principal executive offices) (Zip Code)

 
(763) 225-6600
(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, par value $0.02 per share

NTIC

Nasdaq Global Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ 

Accelerated filer ☐

Non-accelerated filer ☒

Smaller reporting company 

 Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No ☒

 

As of April 5, 2022, there were 9,221,517 shares of common stock of the registrant outstanding.

 

 

 

 

NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION

FORM 10-Q

February 28, 2022

 

TABLE OF CONTENTS

 

Description

 

Page

     

PART I—FINANCIAL INFORMATION

 

Item 1.

Financial Statements

 

 

Consolidated Balance Sheets as of February 28, 2022 (unaudited) and August 31, 2021

1

  Consolidated Statements of Operations (unaudited) for the Three and Six Months Ended February 28, 2022 and 2021 2

 

Consolidated Statements of Comprehensive Income (unaudited) for the Three and Six Months Ended February 28, 2022 and 2021

3

  Consolidated Statements of Equity (unaudited) for the Three and Six Months Ended February 28, 2022 and 2021 4

 

Consolidated Statements of Cash Flows (unaudited) for the Six Months Ended February 28, 2022 and 2021

5

 

Notes to Consolidated Financial Statements (unaudited) 6

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

21-39

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

40

Item 4.

Controls and Procedures

40

PART II—OTHER INFORMATION

 

Item 1.

Legal Proceedings

42

Item 1A.

Risk Factors

42

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

43

Item 3.

Defaults Upon Senior Securities

43

Item 4.

Mine Safety Disclosures

43

Item 5.

Other Information

 44

Item 6.

Exhibits

44

SIGNATURES

46

 


 

This quarterly report on Form 10-Q contains certain forward-looking statements that are within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created by those sections. For more information, see Part I. Financial Information Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements.

 

 

i

 


 

As used in this report, references to NTIC, the Company, we, our or us, unless the context otherwise requires, refer to Northern Technologies International Corporation and its wholly-owned and majority-owned subsidiaries, all of which are consolidated on NTICs consolidated financial statements.

 

As used in this report, references to: (1) NTIC China refer to NTICs wholly-owned subsidiary in China, NTIC (Shanghai) Co., Ltd.; (2) NTI Europe refer to NTICs wholly-owned subsidiary in Germany, NTIC Europe GmbH; (3) Zerust Mexico refer to NTICs wholly-owned subsidiary in Mexico, ZERUST-EXCOR MEXICO, S. de R.L. de C.V; (4) Zerust India refer to NTICs wholly-owned subsidiary in India effective as of September 1, 2021, Harita-NTI Limited; and (5)NTI Asean refer to NTICs majority-owned holding company subsidiary, NTI Asean LLC, which holds investments in certain entities that operate in the Association of Southeast Asian Nations (ASEAN) region, including the following countries: Indonesia, South Korea, Malaysia, Philippines, Singapore, Taiwan, Thailand and Vietnam.

 

NTICs consolidated financial statements do not include the accounts of any of its joint ventures. Except as otherwise indicated, references in this report to NTICs joint ventures do not include any of NTICs wholly-owned or majority-owned subsidiaries.

 

As used in this report, references to EXCOR refer to NTICs joint venture in Germany, Excor Korrosionsschutz Technologien und Produkte GmbH.

 

All trademarks, trade names or service marks referred to in this report are the property of their respective owners.

 

 

 

 

 

 

 

 

 

 

 

ii

 

 

PART I - FINANCIAL INFORMATION

 

ITEM 1.         FINANCIAL STATEMENTS

 

NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS AS OF FEBRUARY 28, 2022 (UNAUDITED)

AND AUGUST 31, 2021 (AUDITED)


 

  

February 28, 2022

  

August 31, 2021

 

ASSETS

        

CURRENT ASSETS:

        

Cash and cash equivalents

 $7,487,811  $7,680,641 

Available for sale securities

  4,634   4,634 

Receivables:

        

Trade, excluding joint ventures, less allowance for doubtful accounts of $382,000 as of February 28, 2022 and August 31, 2021

  12,457,917   11,128,805 

Trade, joint ventures

  905,961   624,808 

Fees for services provided to joint ventures

  1,078,702   1,505,127 

Income taxes

  570,483   386,574 

Inventories

  12,978,217   11,114,207 

Prepaid expenses

  3,113,898   1,302,293 

Total current assets

 $38,597,623  $33,747,089 
         

PROPERTY AND EQUIPMENT, NET

 $12,336,699  $11,821,458 

OTHER ASSETS:

        

Investments in joint ventures

  21,852,070   27,623,768 

Deferred income taxes

     92,554 

Patents and trademarks, net

  717,805   709,572 

Goodwill

  4,782,376    

Intangible asset, net

  6,135,433    

Operating lease right of use asset

  528,645   376,438 

Total other assets

  34,016,329   28,802,332 

Total assets

 $84,950,651  $74,370,879 
         

LIABILITIES AND EQUITY

        

CURRENT LIABILITIES:

        

Accounts payable

 $5,948,430  $4,290,972 

Line of credit

  4,200,000    

Income taxes payable

  152,183   178,923 

Accrued liabilities:

        

Payroll and related benefits

  1,694,506   2,879,468 

Other

  1,091,861   894,497 

Current portion of operating lease

  184,206   272,336 

Total current liabilities

 $13,271,186  $8,516,196 

LONG-TERM LIABILITIES:

        

Deferred income tax, net

  1,897,259    

Operating lease, less current portion

  344,439   104,102 

Total long-term liabilities

 $2,241,698  $104,102 
         

COMMITMENTS AND CONTINGENCIES (Note 14)

          
         

EQUITY:

        

Preferred stock, no par value; authorized 10,000 shares; none issued and outstanding

      

Common stock, $0.02 par value per share; authorized 15,000,000 shares as ofFebruary 28, 2022 and August 31, 2021; issued and outstanding 9,221,517 and 9,184,811, respectively

  184,430   183,696 

Additional paid-in capital

  19,379,032   18,736,268 

Retained earnings

  50,361,066   46,973,092 

Accumulated other comprehensive loss

  (3,858,689)  (3,525,030)

Stockholders’ equity

  66,065,839   62,368,026 

Non-controlling interests

  3,371,928   3,382,555 

Total equity

  69,437,767   65,750,581 

Total liabilities and equity

 $84,950,651  $74,370,879 

 

See notes to consolidated financial statements.

 

 

1

 
 

 

NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

FOR THE THREE AND SIX MONTHS ENDED FEBRUARY 28, 2022 AND 2021       


 

  

Three Months Ended February 28,

  

Six Months Ended February 28,

 
  

2022

  

2021

  

2022

  

2021

 

NET SALES:

                

Net sales, excluding joint ventures

 $15,865,128  $12,255,941  $33,218,102  $24,454,749 

Net sales, to joint ventures

  883,511   526,941   1,723,950   1,107,245 

Total net sales

  16,748,639   12,782,882   34,942,052   25,561,994 
                 

Cost of goods sold

  11,764,304   8,531,679   24,254,787   16,845,000 

Gross profit

  4,984,335   4,251,203   10,687,265   8,716,994 
                 

JOINT VENTURE OPERATIONS:

                

Equity in income from joint ventures

  922,832   1,920,012   2,297,581   3,745,724 

Fees for services provided to joint ventures

  1,246,909   1,462,684   2,505,767   2,799,245 

Total joint venture operations

  2,169,741   3,382,696   4,803,348   6,544,969 
                 

OPERATING EXPENSES:

                

Selling expenses

  2,971,391   2,832,008   6,209,149   5,573,776 

General and administrative expenses

  2,518,788   1,958,974   5,115,135   4,052,956 

Research and development expenses

  1,218,674   1,075,180   2,454,495   2,150,917 

Total operating expenses

  6,708,853   5,866,162   13,778,779   11,777,649 
                 

OPERATING INCOME

  445,223   1,767,737   1,711,834   3,484,314 
                 

REMEASUREMENT GAIN ON ACQUISITION OF EQUITY METHOD INVESTEE

        3,951,550    

INTEREST INCOME

  9,909   15,638   20,852   85,176 

INTEREST EXPENSE

  (7,404)  (5,249)  (10,295)  (7,617)

INCOME BEFORE INCOME TAX EXPENSE

  447,728   1,778,126   5,673,941   3,561,873 
                 

INCOME TAX EXPENSE

  151,743   274,660   656,123   653,250 

NET INCOME

  295,985   1,503,466   5,017,818   2,908,623 
                 

NET INCOME ATTRIBUTABLE TO NON-CONTROLLING INTERESTS

  113,138   190,891   341,212   333,649 

NET INCOME ATTRIBUTABLE TO NTIC

 $182,847  $1,312,575  $4,676,606  $2,574,974 
                 

NET INCOME ATTRIBUTABLE TO NTIC PER COMMON SHARE:

                

Basic

 $0.02  $0.14  $0.51  $0.28 

Diluted

 $0.02  $0.13  $0.48  $0.26 
                 

WEIGHTED AVERAGE COMMON SHARES ASSUMED OUTSTANDING:

                

Basic

  9,214,817   9,104,636   9,211,858   9,104,623 

Diluted

  9,683,426   9,867,918   9,736,060   9,756,268 
                 

CASH DIVIDENDS DECLARED PER COMMON SHARE

 $0.07  $0.065  $0.14  $0.065 

 

 

See notes to consolidated financial statements.

 

2

 
 

 

NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

FOR THE THREE AND SIX MONTHS ENDED FEBRUARY 28, 2022 AND 2021


 

  

Three Months Ended February 28,

  

Six Months Ended February 28,

 
  

2022

  

2021

  

2022

  

2021

 

NET INCOME

 $295,985  $1,503,466  $5,017,818  $2,908,623 

OTHER COMPREHENSIVE INCOME (LOSS) –FOREIGN CURRENCY TRANSLATION ADJUSTMENT

  26,295   196,341   (382,769)  495,006 

COMPREHENSIVE INCOME

  322,280   1,699,807   4,635,049   3,403,629 

COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO NON-CONTROLLING INTERESTS

  (136,037)  177,117   (292,102)  387,780 

COMPREHENSIVE INCOME ATTRIBUTABLE TO NTIC

 $458,317  $1,522,690  $4,927,151  $3,015,849 

 

 

See notes to consolidated financial statements.

 

3

 
 

 

NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)

FOR THE THREE AND SIX MONTHS ENDED FEBRUARY 28, 2022 AND 2021

 


 

  

STOCKHOLDERS EQUITY THREE MONTHS ENDED FEBRUARY 28, 2022 AND 2021

         
            
                  

Accumulated

         
          

Additional

      

Other

  

Non-

     
  

Common Stock

  

Paid-in

  

Retained

  

Comprehensive

  

Controlling

  

Total

 
  

Shares

  

Amount

  

Capital

  

Earnings

  

Income (Loss)

  

Interests

  

Equity

 
                             

BALANCE AS OF NOVEMBER 30, 2021

  9,203,446  $184,069  $19,146,510  $50,823,730  $(3,862,085) $3,338,620  $69,630,844 

Stock options exercised

  18,071   361   (361)            

Stock option expense

        232,883            232,883 

Dividends paid to stockholders

           (645,511)        (645,511)

Dividend received by non-controlling interest

                 (102,729)  (102,729)

Net income

           182,847      113,138   295,985 

Other comprehensive income

              3,396   22,899   26,295 

BALANCE AS OF FEBRUARY 28, 2022

  9,221,517  $184,430  $19,379,032  $50,361,066  $(3,858,689) $3,371,928  $69,437,767 
                             

BALANCE AS OF NOVEMBER 30, 2020

  9,104,636  $182,093  $17,632,811  $43,735,209  $(3,179,678) $3,255,689  $61,626,124 

Stock option expense

        160,835            160,835 

Dividends paid to stockholders

           (591,802)        (591,802)

Dividend received by non-controlling interest

                 (200,000)  (200,000)

Net income

           1,312,575      190,891   1,503,466 

Other comprehensive income (loss)

              210,115   (13,774)  196,341 

BALANCE AS OF FEBRUARY 28, 2021

  9,104,636  $182,093  $17,793,646  $44,455,982  $(2,969,563) $3,232,806  $62,694,964 

 

 

  

STOCKHOLDERS EQUITY SIX MONTHS ENDED FEBRUARY 28, 2022 AND 2021

         
            
                  

Accumulated

         
          

Additional

      

Other

  

Non-

     
  

Common Stock

  

Paid-in

  

Retained

  

Comprehensive

  

Controlling

  

Total

 
  

Shares

  

Amount

  

Capital

  

Earnings

  

Income (Loss)

  

Interests

  

Equity

 

BALANCE AS OF AUGUST 31, 2021

  9,184,811  $183,696  $18,736,268  $46,973,092  $(3,525,030) $3,382,555  $65,750,581 

Stock options exercised

  34,071   681   138,519            139,200 

Stock issued for employee stock

purchase plan

  2,635   53   38,479            38,532 

Stock option expense

        465,766            465,766 

Dividends paid to stockholders

           (1,288,632)        (1,288,632)

Dividend received by non-controlling interest

                 (302,729)  (302,729)

Net income

           4,676,606      341,212   5,017,818 

Other comprehensive loss

              (333,659)  (49,110)  (382,769)

BALANCE AS OF FEBRUARY 28, 2022

  9,221,517  $184,430  $19,379,032  $50,361,066  $(3,858,689) $3,371,928  $69,437,767 
                             

BALANCE AS OF AUGUST 31, 2020

  9,099,990  $182,000  $17,415,043  $42,472,810  $(3,410,438) $3,045,026  $59,704,441 

Stock issued for employee stock

purchase plan

  4,646   93   36,099            36,192 

Stock option expense

        342,504            342,504 

Dividends paid to stockholders

           (591,802)        (591,802)

Dividend received by non-controlling interest

                 (200,000)  (200,000)

Net income

           2,574,974      333,649   2,908,623 

Other comprehensive income

              440,875   54,131   495,006 

BALANCE AS OF FEBRUARY 28, 2021

  9,104,636  $182,093  $17,793,646  $44,455,982  $(2,969,563) $3,232,806  $62,694,964 

 

 

See notes to consolidated financial statements.

 

4

 
 

 

NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
FOR THE SIX MONTHS ENDED FEBRUARY 28, 2022 AND 2021        


 

  

Six Months Ended February 28,

 
  

2022

  

2021

 

CASH FLOWS FROM OPERATING ACTIVITIES:

        

Net income

 $5,017,818  $2,908,623 

Adjustments to reconcile net income to net cash provided by operating activities:

        

Stock-based compensation

  465,766   342,504 

Depreciation expense

  430,991   451,498 

Amortization expense

  315,631   100,821 

Change in allowance for doubtful accounts

     10,000 

Remeasurement gain on acquisition of equity method investee

  (3,951,550)   

Equity in income from joint ventures

  (2,297,581)  (3,745,724)

Dividends received from joint ventures

  5,362,636   3,323,503 

Deferred income taxes

  139,338   (3,182)

Changes in current assets and liabilities:

        

Receivables:

        

Trade, excluding joint ventures

  321,322   (2,004,152)

Trade, joint ventures

  (281,153)  27,879 

Fees for services provided to joint ventures

  426,425   (388,590)

Income taxes

  (286,458)  (270,867)

Inventories

  (990,628)  (83,028)

Prepaid expenses and other

  (1,136,130)  (450,263)

Accounts payable

  674,147   1,036,818 

Income tax payable

  (376,544)  290,252 

Accrued liabilities

  (1,715,302)  413,157 

Net cash provided by operating activities

  2,118,728   1,959,249 
         

CASH FLOWS FROM INVESTING ACTIVITIES:

        

Acquisition of Zerust India business, net of cash acquired (see Note 3)

  (5,062,003)   

Purchase of available for sale securities

     (868,758)

Proceeds from the sale of available for sale securities

     500,000 

Purchases of property and equipment

  (618,533)  (466,572)

Investments in patents

  (112,297)  (75,220)

Net cash used in investing activities

  (5,792,833)  (910,550)
         

CASH FLOWS FROM FINANCING ACTIVITIES:

        

Proceeds from line of credit

  4,200,000    

Dividends paid on NTIC common stock

  (1,288,632)  (591,802)

Proceeds from the exercise of stock options

  139,200    

Dividends received by non-controlling interest

  (302,729)  (200,000)

Proceeds from employee stock purchase plan

  38,532   36,192 

Net cash provided by (used in) financing activities

  2,786,371   (755,610)
         

EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS

  694,904   92,414 
         
         

NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS

  (192,830)  385,503 

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD

  7,680,641   6,403,032 
         

CASH AND CASH EQUIVALENTS AT END OF PERIOD

 $7,487,811  $6,788,535 

 

 

See notes to consolidated financial statements.

 

5

 

NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


 

 

1.         INTERIM FINANCIAL INFORMATION

 

In the opinion of management, the accompanying unaudited consolidated financial statements contain all necessary adjustments, which are of a normal recurring nature, and present fairly the consolidated financial position of Northern Technologies International Corporation and its subsidiaries (the Company) as of February 28, 2022 and August 31, 2021, the results of the Company’s operations for the three and six months ended February 28, 2022 and 2021, the changes in stockholders’ equity for the three and six months ended February 28, 2022 and 2021, and the Company’s cash flows for the six months ended February 28, 2022 and 2021, in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP).

 

These consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes contained in the Company’s annual report on Form 10-K for the fiscal year ended August 31, 2021. These consolidated financial statements also should be read in conjunction with the “Managements Discussion and Analysis of Financial Condition and Results of Operations” section appearing in this report.

 

Operating results for the three and six months ended February 28, 2022 are not necessarily indicative of the results that may be expected for the full fiscal year ending August 31, 2022.

 

The Company evaluates events occurring after the date of the consolidated financial statements requiring recording or disclosure in the consolidated financial statements.

 

Impact of COVID-19 Pandemic

 

In March 2020, the World Health Organization declared the novel coronavirus (COVID-19) outbreak a global pandemic. As a result of the COVID-19 pandemic and related government mandated restrictions on the Company’s business as well as the businesses of its joint ventures, customers and suppliers, disruption to the Company’s business and the manufacture and sale of its products and services has occurred in the first six months of fiscal 2022 and is expected to continue during the remainder of fiscal 2022. In the first six months of fiscal 2022, the Company was impacted by shipping issues, including freight container shortages, shipping delays, and increased costs, and supply chain issues, including longer lead times and raw material cost increases.

 

 

2.         ACCOUNTING PRONOUNCEMENTS

 

Recently Issued Accounting Pronouncements

 

In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-13, Measurement of Credit Losses on Financial Instruments, which revises guidance for the accounting for credit losses on financial instruments within its scope, and in November 2018, issued ASU No. 2018-19 and in April 2019, issued ASU No. 2019-04 and in May 2019, issued ASU No. 2019-05, and in November 2019, issued ASU No. 2019-11, which amended the standard. The new standard introduces an approach, based on expected losses, to estimate credit losses on certain types of financial instruments and modifies the impairment model for available-for-sale debt securities. The new approach to estimating credit losses (referred to as the current expected credit losses model) applies to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities, net investments in leases and off-balance-sheet credit exposures. This ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, with early adoption permitted. Entities are required to apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. The Company is still evaluating the impact of this ASU.

 

6

 

Although there are several other new accounting pronouncements issued or proposed by the FASB, which the Company has adopted or will adopt, as applicable, the Company does not believe any of these accounting pronouncements has had or will have a material impact on the Company’s consolidated financial position or operating results.

 

 

3.         BUSINESS COMBINATION

 

On September 21, 2021, the Company announced that it acquired the remaining 50% ownership interest in its Indian joint venture, Harita-NTI Limited (Zerust India), for $6,250,000 in cash, effective as of September 1, 2021, the date the Company obtained control. Prior to September 1, 2021, the Company owned 50% of the outstanding capital stock of Zerust India. The Company had historically accounted for this investment under the equity method of accounting. This purchase was funded with cash on hand and borrowings under the Company’s revolving line of credit. The Company undertook the acquisition to enhance its Zerust business in India.

 

The purchase price of $6,250,000 was funded with cash on hand and borrowings under the Company’s revolving line of credit, which was increased in connection with the transaction to $5,000,000.

 

Because the Company increased its ownership interest in Zerust India to 100%, the acquisition of Zerust India has been accounted for in accordance with Accounting Standards Codification (ASC) 805, Business Combinations, by using the acquisition method of accounting. Effective September 1, 2021, Zerust India is now a consolidated subsidiary within the Company’s financial statements.

 

The following table summarizes the purchase price allocation that includes the fair values of the separately identifiable assets acquired and liabilities assumed as of September 1, 2021:

 

Cash and cash equivalents

 $1,187,997 

Trade account receivable

  1,954,769 

Inventories

  886,650 

Prepaid expenses and other

  396,545 

Property, plant and equipment

  219,077 

Operating lease, right of use asset

  355,000 

Customer relationships

  6,347,000 

Goodwill

  4,782,376 

Current liabilities

  (1,370,314)

Deferred tax liability

  (1,904,100)

Operating lease liability

  (355,000)
 

Net assets acquired

 $12,500,000 

Less:

     
 

Fair value of previously held equity method investment

  (1,637,362)
 

Cumulative foreign currency translation

  (661,088)
 

Gain recognized on acquisition

  (3,951,550)
    (6,250,000)

Cash paid for acquisition

 $6,250,000 

 

7

 

The excess of the fair value of purchase consideration over the fair value of net tangible and identifiable intangible assets acquired was recorded as goodwill. The fair values assigned to tangible and identifiable intangible assets acquired and liabilities assumed are based on management’s estimates and assumptions. The fair values of assets acquired and liabilities assumed may be subject to change as additional information is received.

 

The fair value of the intangible asset associated with customer relationships was estimated using a discounted cash flow method with the application of the multi-period excess earnings method. Under this method, an intangible asset’s fair value is equal to the present value of the incremental after-tax cash flows attributable to only the subject intangible asset after deducting contributory asset charges.

 

The rate used to discount the estimated future net cash flows to their present values for the intangible assets was based upon a weighted average cost of capital calculation. The discount rate was determined after consideration of market rates of return on debt and equity capital, the weighted average return on invested capital and the risk associated with achieving forecasted sales related to the assets acquired from Zerust India. The weighted average discount rate used to determine the fair value of the customer relationships was 15.3%.

 

The amortization period for the intangible assets is 15 years. The intangible assets are being amortized on a straight-line basis, which is consistent with the pattern that the economic benefits of the intangible assets are expected to be utilized based upon estimated cash flows generated from such asset. Goodwill associated with the acquisition was primarily attributable to the expansion opportunity of the Company’s ZERUST business in India.

 

Authoritative guidance on accounting for business combinations requires that an acquirer re-measure its previously held equity interest in the acquisition at its acquisition date fair value and recognize the resulting gain or loss in earnings. As such, since the Company acquired the remaining 50% ownership interest of Zerust India effective September 1, 2021, the Company recognized a gain of $3,951,550 during the six months ended February 28, 2022. This gain is included in “Remeasurement gain on acquisition of equity method investee” on the Company’s consolidated statements of operations for the three and six months ended February 28, 2022.

 

The Company has included the financial results of Zerust India in the consolidated financial statements from September 1, 2021. Net revenue and net income related to Zerust India since the date of acquisition totaled $4,680,103 and $496,748, respectively. The transaction costs associated with the acquisition were approximately $65,000 and $115,000, respectively, and are recorded in general and administrative expense as incurred during the three and six months ended February 28, 2022.

 

8

 
 

Unaudited consolidated pro forma information assuming the acquisition had occurred on September 1, 2020 for the three and six months ended February 28, 2022 would have an increase in net sales $2,257,542 and $4,271,892, respectively. Unaudited pro forma net income, assuming the acquisition had occurred on September 1, 2020, for the three and six months ended February 28, 2022 was not considered material to the Company’s consolidated net income. The unaudited consolidated pro forma combined financial information does not purport to be indicative of the results which would have been obtained had the acquisition been completed as of the beginning of the earliest period presented or of results that may be obtained in the future. In addition, they do not include any benefits that may result from the acquisition due to synergies that may be derived from the elimination of any duplicative costs.

 

 

4.         INVENTORIES

 

Inventories consisted of the following:

 

  

February 28, 2022

  

August 31, 2021

 

Production materials

 $5,016,068  $4,453,688 

Finished goods

  7,962,149   6,660,519 
  $12,978,217  $11,114,207 

 

 

5.         PROPERTY AND EQUIPMENT, NET

 

Property and equipment, net consisted of the following:

 

  

February 28, 2022

  

August 31, 2021

 

Land

 $310,365  $310,365 

Buildings and improvements

  14,084,196   13,149,258 

Machinery and equipment

  5,540,345   5,453,679 
   19,934,906   18,913,302 

Less accumulated depreciation

  (7,598,207)  (7,091,844)
  $12,336,699  $11,821,458 

 

 

6.         PATENTS AND TRADEMARKS, NET

 

Patents and trademarks, net consisted of the following:

 

  

February 28, 2022

  

August 31, 2021

 

Patents and trademarks

 $3,130,803  $3,018,507 

Less accumulated amortization

  (2,412,998)  (2,308,935)
  $717,805  $709,572 

 

 

7.         INVESTMENTS IN JOINT VENTURES

 

The consolidated financial statements of the Company’s foreign joint ventures are initially prepared using the accounting principles accepted in the respective joint ventures’ countries of domicile. Amounts related to foreign joint ventures reported in the below tables and the accompanying consolidated financial statements have subsequently been adjusted to conform with U.S. GAAP in all material respects. All material profits on sales recorded that remain on the consolidated balance sheet from the Company to its joint ventures and from joint ventures to other joint ventures have been eliminated for financial reporting purposes.

 

9

 
 

Financial information from the audited and unaudited financial statements of the Company’s joint venture in Germany, Excor Korrosionsschutz – Technologien und Produkte GmbH (EXCOR), and all the Company’s other joint ventures are summarized as follows:

 

  

As of February 28, 2022

 
  

Total

  

EXCOR

  

All Other

 

Current assets

 $55,032,109  $25,447,104  $29,585,005 

Total assets

  58,525,731   27,186,903   31,338,828 

Current liabilities

  12,803,351   3,004,495   9,798,856 

Noncurrent liabilities

  1,268,334   -   1,268,334 

Joint ventures’ equity

  44,454,046   24,182,408   20,271,638 

Northern Technologies International Corporation’s share of joint ventures’ equity

  21,852,070   12,091,206   9,760,864 

Northern Technologies International Corporation’s share of joint ventures’ undistributed earnings

  20,501,921   12,060,301   8,441,621 

 

  

Three Months Ended February 28, 2022

 
  

Total

  

EXCOR

  

All Other

 

Net sales

 $24,601,767  $9,312,434  $15,289,334 

Gross profit

  9,845,002   4,658,450   5,186,553 

Net income

  1,851,591   1,170,187   681,404 

Northern Technologies International Corporation’s share of equity in income from joint ventures

  922,832   589,048   333,784 

Northern Technologies International Corporation's dividends received from joint ventures

  320,365      320,365 

 

  

Six Months Ended February 28, 2022

 
  

Total

  

EXCOR

  

All Other

 

Net sales

 $51,624,762  $20,612,662  $31,012,100 

Gross profit

  20,877,961   10,127,436   10,750,525 

Net income

  4,629,196   2,991,734   1,637,462 

Northern Technologies International Corporation’s share of equity in income from joint ventures

  2,297,581   1,499,821   797,760 

Northern Technologies International Corporation's dividends received from joint ventures

  5,362,636   4,255,200   1,107,436 

 

10

 
  

As of August 31, 2021

 
  

Total

  

EXCOR

  

All Other(1)

 

Current assets

 $69,394,796  $33,886,655  $35,508,141 

Total assets

  73,814,402   36,211,520   37,602,882 

Current liabilities

  16,366,398   5,386,377   10,980,021 

Noncurrent liabilities

  1,455,524      1,455,524 

Joint ventures’ equity

  55,992,480   30,825,144   25,167,336 

Northern Technologies International Corporation’s share of joint ventures’ equity

  27,623,768   15,412,574   12,211,194 

Northern Technologies International Corporation’s share of joint ventures’ undistributed earnings

  24,702,778   14,697,490   10,005,288 

 

  

Three Months Ended February 28, 2021

 
  

Total

  

EXCOR

  

All Other(1)

 

Net sales

 $29,058,402  $10,542,097  $18,516,306 

Gross profit

  13,079,478   6,099,187   6,980,291 

Net income

  3,838,007   2,262,321   1,575,686 

Northern Technologies International Corporation’s share of equity in income from joint ventures

  1,920,012   1,132,578   787,434 

Northern Technologies International Corporation's dividends received from joint ventures

  2,198,142   1,809,900   388,242 

 

  

Six Months Ended February 28, 2021

 
  

Total

  

EXCOR

  

All Other(1)

 

Net sales

 $55,835,745  $20,093,580  $35,742,165 

Gross profit

  25,521,239   11,798,194   13,723,045 

Net income

  7,489,431   4,283,395   3,206,036 

Northern Technologies International Corporation’s share of equity in income from joint ventures

  3,745,724   2,143,115   1,602,609 

Northern Technologies International Corporation's dividends received from joint ventures

  3,323,503   1,809,900   1,513,603 

 


(1)         Includes Zerust India since Zerust India was not a consolidated subsidiary of the Company as of August 31, 2021 or February 28, 2021. See Note 3 entitled “Business Combination.”

 

11

 
 

 

 

8.         INTANGIBLE ASSET, NET

 

Intangible asset, net consisted of the following as of February 28, 2022:

 

  

Gross Carrying Amount

  

Accumulated Amortization

  

Net Carrying Amount

 

Customer relationships

 $6,347,000  $(211,567) $6,135,433 

 

The customer relationships was established as a part of purchase accounting related to our Zerust India acquisition. See Note 3 entitled “Business Combination.” The Company amortizes the intangible asset related to the customer relationships using the straight-line method over the estimated useful lives of the asset, which is 15 years. Total amortization expense was $143,567 and $211,567 for the three and six months ended February 28, 2022, respectively. Amortization expense is estimated to be $423,000 in each of the next five fiscal years.

 

 

9.         CORPORATE DEBT

 

The Company has a revolving line of credit with PNC Bank, National Association (PNC Bank) of $5,000,000 as of February 28, 2022. On August 31, 2021, in connection with the Company’s acquisition of Zerust India, the Company and PNC Bank entered into an Amended and Restated Revolving Line of Credit Note, which increased the Company’s line of credit from $3,000,000 to $5,000,000 until February 22, 2022. Additionally, on January 4, 2022, the Company and PNC Bank entered into an Amended and Restated Revolving Line of Credit Note, which extended the maturity date to January 7, 2023 and revised the rate at which amounts outstanding under the line of credit bear interest to equal a per annum rate equal to the daily Bloomberg Short-Term Bank Yield Index plus 250 basis points (2.50%) and maintained the line of credit’s capacity at $5,000,000 during the period from January 4, 2022 until February 22, 2022 and $3,000,000 at all other times. Subsequently, to maintain future financial flexibility, the Company and PNC Bank agreed to keep the line of credit at $5,000,000. A 30-day extension was provided by PNC Bank on February 23, 2022 in order to ensure line of credit capacity between February 23, 2022 and March 1, 2022. On March 1, 2022, the Company and PNC Bank entered into an Amended and Restated Revolving Line of Credit Note, which established a line of credit of $5,000,000 during the period from February 23, 2022 until April 23, 2022 and $3,000,000 at all other times. The other material terms of the line of credit were not affected by these amendments.

 

Borrowings of $4,200,000 were outstanding under the line of credit as of February 28, 2022 and no amounts were outstanding as of August 31, 2021. The weighted average interest rate during each of the three and six months ended February 28, 2022 was 2.57%.

 

The line of credit is governed under an Amended and Restated Loan Agreement dated August 31, 2021. The obligations of the Company under the loan agreement are secured by a lien on all of the Company’s personal property, excepting certain liens consented to in writing by PNC. The loan agreement contains covenants, including affirmative financial covenants, such as the maintenance of a minimum fixed charge coverage ratio of 1.10:1.00, and negative covenants, which, among other things, limit the incurrence of additional indebtedness, loans and equity investments, disposition of assets, mergers and consolidations and other matters customarily restricted in such agreements. As of February 28, 2022, the Company was in compliance with all debt covenants.

 

12

 
 

As of February 28, 2022 and August 31, 2021, the Company did not have any letters of credit outstanding with respect to the letter of credit sub-facility available under the revolving line of credit with PNC Bank. As of February 28, 2022 and August 31, 2021, the Company had $72,418 of letters of credit with JP Morgan Chase Bank that are performance based and set to expire between 2021 and 2022.

 

 

10.       STOCKHOLDERS EQUITY

 

During the six months ended February 28, 2022, the Company’s Board of Directors declared cash dividends on the following dates in the following amounts to the following holders of the Company’s common stock:

 

Declaration Date

 

Amount

 

Record Date

 

Payable Date

October 20, 2021

 $0.07 

November 3, 2021

 

November 17, 2021

January 21, 2022

 $0.07 

February 2, 2022

 

February 16, 2022

 

During the six months ended February 28, 2022 and 2021, the Company repurchased no shares of its common stock.

 

During the six months ended February 28, 2022, the Company granted stock options under the Northern Technologies International Corporation 2019 Stock Incentive Plan (as amended, the 2019 Plan) to purchase an aggregate of 174,840 shares of its common stock to various employees and directors. The weighted average per share exercise price of the stock options is $16.97. The exercise price of the stock options is equal to the fair market value of the Company’s common stock on the date of grant. During the six months ended February 28, 2022, stock options to purchase an aggregate of 43,218 shares of common stock were exercised at a weighted average exercise price of $6.45 per share, resulting in the net issuance of 34,071 shares of common stock since some of the options were exercised on a net cashless exercise basis.

 

During the six months ended February 28, 2021, the Company’s Board of Directors declared a cash dividend of $0.065 per share of the Company’s common stock, payable on February 17, 2021 to stockholders of record on February 3, 2021. Prior to such time, the Company had suspended its quarterly cash dividend on April 23, 2020 pending clarity on the financial impact of COVID-19 on the Company.

 

During the six months ended February 28, 2021, the Company granted stock options under the 2019 Plan to purchase an aggregate of 419,874 shares of its common stock to various employees and directors. The weighted average per share exercise price of the stock options is $8.24. The exercise price of the stock options is equal to the fair market value of the Company’s common stock on the date of grant. During the six months ended February 28, 2021, no stock options to purchase common stock were exercised.

 

The Company issued 2,636 and 4,646 shares of common stock on September 1, 2021 and 2020, respectively, under the Northern Technologies International Corporation Employee Stock Purchase Plan (ESPP). As of February 28, 2022, 72,186 shares of common stock remained available for sale under the ESPP.

 

 

11.       NET INCOME PER COMMON SHARE

 

Basic net income per common share is computed by dividing net income by the weighted average number of common shares outstanding. Diluted net income per share assumes the exercise of stock options using the treasury stock method, if dilutive.

 

13

 
 

The following is a reconciliation of the net income per share computation for the three and six months ended February 28, 2022 and 2021:

 

  

Three Months Ended February 28,

  

Six Months Ended February 28,

 

Numerator:

 

2022

  

2021

  

2022

  

2021

 

Net income attributable to NTIC

 $182,847  $1,312,575  $4,676,606  $2,574,974 
                 

Denominator:

                

Basic – weighted shares outstanding

  9,214,817   9,104,636   9,211,858   9,104,623 

Weighted shares assumed upon exercise of stock options

  468,609   763,282   524,202   651,645 

Diluted – weighted shares outstanding

  9,683,426   9,867,918   9,736,060   9,756,268 

Basic net income per share:

 $0.02  $0.14  $0.51  $0.28 

Diluted net income per share:

 $0.02  $0.13  $0.48  $0.26 

 

The dilutive impact summarized above relates to the periods when the average market price of the Company’s common stock exceeded the exercise price of the potentially dilutive option securities granted. Net income per common share was based on the weighted average number of common shares outstanding during the periods when computing basic net income per share. When dilutive, stock options are included as equivalents using the treasury stock market method when computing the diluted net income per share. Excluded from the computation of diluted net income per share for the three and six months ended February 28, 2022 were options outstanding to purchase 311,061 shares of common stock. Excluded from the computation of diluted net income per share for the three and six months ended February 28, 2021, were options outstanding to purchase 136,221 shares of common stock.

 

 

12.       STOCK-BASED COMPENSATION

 

The Company has three stock-based compensation plans under which stock options or other stock-based awards have been granted: the Northern Technologies International Corporation Amended and Restated 2019 Stock Incentive Plan, the Northern Technologies International Corporation Amended and Restated 2007 Stock Incentive Plan (2007 Plan) and the Northern Technologies International Corporation Employee Stock Purchase Plan. The 2019 Plan replaced the 2007 Plan with respect to future grants; and, therefore, no further awards may be made under the 2007 Plan. The Compensation Committee of the Board of Directors and the Board of Directors administer these plans.

 

The 2019 Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, stock unit awards, performance awards, and stock bonuses to eligible recipients to enable the Company and its subsidiaries to attract and retain qualified individuals through opportunities for equity participation in the Company and to reward those individuals who contribute to the achievement of the Company’s economic objectives. On January 15, 2021, the Company’s stockholders approved certain amendments to the 2019 Plan, including an increase in the number of shares of common stock available for issuance under the plan by an additional 800,000 shares. Subject to adjustment as provided in the 2019 Plan, up to a maximum of 1,600,000 shares of the Company’s common stock are issuable under the 2019 Plan. Options granted generally have a term of ten years and become exercisable over a one- or three- year period beginning on the one-year anniversary of the date of grant. Options are granted at per share exercise prices equal to the market value of the Company’s common stock on the date of grant. The Company issues new shares upon the exercise of options. As of February 28, 2022, options to purchase an aggregate of 895,484 shares of the Company’s common stock were outstanding under the 2019 Plan and 704,516 shares of the Company’s common stock remain available for grant under the 2019 Plan. As of February 28, 2022, options to purchase an aggregate of 662,789 shares of the Company’s common stock were outstanding under the 2007 Plan.

 

14

 

The Company granted options to purchase an aggregate of 174,840 and 419,874 shares of its common stock during the six months ended February 28, 2022 and 2021, respectively. The fair value of option grants is determined at the date of grant using the Black-Scholes option pricing model with the assumptions listed below. The Company recognized compensation expense of $133,334 and $266,668 during the three and six months ended February 28, 2022, respectively, and compensation expense of $66,667 and $133,334 during the three and six months ended February 28, 2021, respectively, related to the options that vested during such time period. As of February 28, 2022, the total compensation cost for non-vested options not yet recognized in the Company’s consolidated statements of operations was $1,475,485. Stock-based compensation expense of $465,766 is expected through the remainder of fiscal year 2022 and $671,526 and $338,193 is expected to be recognized during fiscal 2023 and fiscal 2024, respectively, based on outstanding options as of February 28, 2022. Future option grants will impact the compensation expense recognized. Stock-based compensation expense is included in general and administrative expense on the consolidated statements of operations.

 

The fair value of each option grant is estimated on the grant date using the Black-Scholes option pricing model with the following assumptions and results for the grants:

 

  

Three and Six Months Ended February 28,

 
  

2022

  

2021

 

Dividend yield

  1.65%  2.37%

Expected volatility

  45.4%  45.6%

Expected life of option (in years)

  10   10 

Average risk-free interest rate

  0.77%  0.28%

 

The weighted average per share fair value of options granted during the six months ended February 28, 2022 and 2021 was $7.29 and $3.12, respectively. The weighted average remaining contractual life of the options outstanding as of February 28, 2022 and 2021 was 6.25 years and 6.65 years, respectively.

 

 

13.       SEGMENT AND GEOGRAPHIC INFORMATION

 

Segment Information

 

The Company’s chief operating decision maker is its Chief Executive Officer. The Company’s business is organized into two reportable segments: ZERUST® and Natur-Tec®. The Company has been selling its proprietary ZERUST® rust and corrosion inhibiting products and services to the automotive, electronics, electrical, mechanical, military and retail consumer markets for over 45 years and, more recently, has targeted and expanded into the oil and gas industry. The Company also sells a portfolio of bio-based and compostable (fully biodegradable) polymer resins and finished products under the Natur-Tec® brand.

 

The following table sets forth the Company’s net sales for the three and six months ended February 28, 2022 and 2021 by segment:

 

  

Three Months Ended February 28,

  

Six Months Ended February 28,

 
  

2022

  

2021

  

2022

  

2021

 

ZERUST® net sales

 $13,117,777  $10,284,116  $27,541,562  $20,504,667 

Natur-Tec® net sales

  3,630,862   2,498,766   7,400,490   5,057,327 

Total net sales

 $16,748,639  $12,782,882  $34,942,052  $25,561,994 

 

15

 

The following table sets forth the Company’s cost of goods sold for the three and six months ended February 28, 2022 and 2021 by segment:

 

  

Three Months Ended February 28,

  

Six Months Ended February 28,

 
  

2022

  

% of

Product

Sales*

  

2021

  

% of

Product

Sales*

  

2022

  

% of

Product

Sales*

  

2021

  

% of

Product

Sales*

 

Direct cost of goods sold

                                

ZERUST®

 $8,151,274   62.1% $6,065,963   59.0% $16,857,941   61.2% $11,837,052   57.7%

Natur-Tec®

  2,775,436   76.4%  1,684,180   67.4%  5,697,533   77.0%  3,451,810   68.3%

Indirect cost of goods sold

  837,594      781,536      1,699,313      1,556,138    

Total net cost of goods sold

 $11,764,304      $8,531,679      $24,254,787      $16,845,000     

 


*         The percent of segment sales is calculated by dividing the direct cost of goods sold for each individual segment category by the net sales for each segment category.

 

The Company utilizes product net sales and direct and indirect cost of goods sold for each product in reviewing the financial performance of a product type. Further allocation of Company expenses or assets, aside from amounts presented in the tables above, is not utilized in evaluating product performance, nor does such allocation occur for internal financial reporting.

 

Geographic Information

 

Net sales by geographic location for the three and six months ended February 28, 2022 and 2021 were as follows:

 

  

Three Months Ended February 28,

  

Six Months Ended February 28,

 
  

2022

  

2021

  

2022

  

2021

 

Inside the U.S.A. to unaffiliated customers

 $5,115,963  $4,619,130  $11,272,285  $9,480,485 

Outside the U.S.A. to:

                

Joint ventures in which the Company is a shareholder directly and indirectly

  883,513   526,942   1,723,952   1,107,246 

Unaffiliated customers

  10,749,163   7,636,810   21,945,815   14,974,262 
  $16,748,639  $12,782,882  $34,942,052  $25,561,994 

 

Net sales by geographic location are based on the location of the customer.

 

16

 
 

Fees for services provided to joint ventures by geographic location as a percentage of total fees for services provided to joint ventures during the three and six months ended February 28, 2022 and 2021 were as follows:

 

  

Three Months Ended February 28,

 
  

2022

  

% of Total Fees for Services Provided to Joint Ventures

  

2021

  

% of Total Fees for Services Provided to Joint Ventures

 

Germany

 $216,992   17.4% $231,917   15.9%

Poland

  172,700   13.9%  210,943   14.4%

Japan

  151,933   12.2%  181,493   12.4%

France

  115,663   9.3%  97,638   6.7%

Sweden

  99,178   8.0%  146,896   10.0%

United Kingdom

  86,736   7.0%  71,759   4.9%

Thailand

  87,918   7.1%  107,377   7.3%

Finland

  85,426   6.9%  71,496   4.9%

Czech Republic

  69,386   5.6%  89,538   6.1%

South Korea

  64,173   5.1%  78,220   5.3%

Other

  96,804   7.5%  175,407   12.0%
  $1,246,909   100.0% $1,462,684   100.0%

 

  

Six Months Ended February 28,

 
  

2022

  

% of Total Fees for Services Provided to Joint Ventures

  

2021

  

% of Total Fees for Services Provided to Joint Ventures

 

Germany

 $435,422   17.4% $460,744   16.5%

Poland

  349,626   14.0%  400,353   14.3%

Japan

  318,740   12.7%  361,455   12.9%

France

  231,958   9.3%  203,545   7.3%

Sweden

  207,248   8.3%  237,385   8.5%

Thailand

  181,663   7.2%  133,674   4.8%

South Korea

  175,472   7.0%  197,309